Vysens
Vysens B.V. develops CellVysion, the only label-free SPR imaging platform for characterizing the functional avidity of T-cell engagers (TCEs) on living cells. CellVysion compares how strongly a TCE binds across different cell types, helping developers assess the desired selectivity profile: high avidity for intended target cell types and low avidity for healthy or off-target cells. Using a continuous ligand-density gradient under flow, it measures the ligand density required for stable attachment and differences within heterogeneous cell populations in real-time.
